Sequencing and Second-Line Therapy in RCC: Patient Scenario

Expert oncologists discuss the challenges and considerations in choosing second-line therapy for a patient with metastatic renal cell carcinoma (RCC) in a case-based context.

Related Keywords

,Optimizing Therapy ,Advanced Renal Cell Carcinoma ,Second Line Therapy ,Patient Scenario ,Renal Cell Carcinoma ,Metastatic Rcc ,Kidney Cancer ,Sequencing ,Case Based Discussion ,Adjuvant Therapy ,Immune Therapy ,Metastatic Kidney Cancer ,Treatment Choice ,Pembrolizumab ,Clinical Trial ,Tki Based Therapy ,Adjuvant Treatment ,Risk Factors ,Quality Of Life ,Therapy Sequence ,Progression ,Cabozantinib ,Axitinib ,Everolimus ,Drug Interaction ,